How Innovation Happens — Lesson #33: Instill a Sense of Courage

I've been covering the link between future trends and innovation strategies for 30+ years. I went back through my blog posts, stretching to 2002, to dig out the nuggets of innovation insight I've discovered along the way. This series revisits those stories, tests what still holds up, and turns them into practical lessons for what comes next.


One thing I've learned from working with organizations around the world is that culture reveals itself most clearly in what happens immediately after someone raises a new idea. The reaction in that moment tells you far more than the innovation language in the annual report.

Innovation requires more than process. It requires courage.

During periods of economic or organizational stress, people naturally retreat toward safety. Budgets tighten, decisions slow and risk tolerance collapses. Yet that is often exactly when competitors are creating the next advantage.

Courage is not recklessness. It is the willingness to move when the facts justify movement but fear argues for delay.

Leaders create courage by making it safe to experiment, safe to question and safe to acknowledge uncertainty.

This is where culture either reinforces the future or quietly kills it. If you want to change the pattern, start with these three moves.

Action Items:

  • Name one decision fear is delaying.
  • Clarify what level of failure is acceptable before a project begins.
  • Reward someone who raised a difficult issue rather than punishing the discomfort it caused.

Explore the full How Innovation Happens series.


Real-World Examples

These researched examples show the lesson at work in the real world.

Firestone Liberia: A rubber plantation builds an Ebola response

When Ebola reached the vast Firestone rubber plantation in Liberia in March 2014, the company faced a crisis that was larger than its normal industrial mission. Its operations supported thousands of employees and family members, and a contagious disease threatened both the workforce and nearby communities. Waiting for every resource to be provided by an overstretched national health system was not a realistic strategy.

After the first known case was reported on 30 March, Firestone established an incident-management system on 31 March. It organized early case identification and isolation, contact tracing, exposure-based monitoring and risk communication through local radio and meetings. The company drew on its existing healthcare facilities and organizational infrastructure to assemble a coordinated response.

A Centers for Disease Control and Prevention investigation documented the response in detail, including its dedicated care and monitoring practices. The report does not establish that one organization could solve Liberia's Ebola epidemic. It shows something narrower and more useful: a complex enterprise acting decisively within its area of responsibility while working with public authorities.

Courage here did not mean improvising recklessly against medical advice. It meant committing facilities, people and leadership attention to an unfamiliar threat, then adapting the response to evidence and guidance. In a crisis, a company discovers whether its values are backed by the ability to organize action.

Why it matters: Courageous leadership commits real resources to a defined risk while retaining operational discipline and expert guidance.

Sources:

Alain Cribier: Replacing a heart valve without opening the chest

For patients with severe aortic stenosis, heart-valve replacement once generally meant major surgery. Some very sick patients could not survive that operation and had few alternatives. French cardiologist Alain Cribier spent years exploring a radically different possibility: delivering a replacement valve through a catheter rather than performing open-heart surgery.

The concept encountered enormous practical obstacles. The valve had to be compressed small enough to travel through blood vessels, positioned precisely and expanded while the heart remained in a fragile state. Cribier described years of bench experiments, animal studies and skepticism before the first patient could be treated. This was neither a spontaneous gamble nor a straightforward application of settled practice.

On 16 April 2002, at Charles Nicolle University Hospital in Rouen, Cribier's team implanted a replacement aortic valve in a critically ill patient who had been declined for conventional surgery. Cribier's published account describes the initial clinical milestone and the long technical path leading to it. Subsequent studies, redesigns and regulatory approvals helped turn the approach into an important treatment option.

The courage lay in doing years of disciplined work to make an apparently unreasonable option clinically possible, then acting when an appropriate high-risk case arose. Innovation courage is not always moving faster. Sometimes it means persisting when the institution's conventional answer leaves people without a viable future.

Why it matters: Courage matters most when it is paired with years of preparation, transparent risk assessment and a patient-focused purpose.

Sources: